Japan's Supercentenarians in 2026: World Rankings, Age Validation, and the Longevity Science Behind Living Past 110

Jul 4, 2026 8 min read

Affiliate disclosure: Some links in this article are affiliate links. We may earn a commission at no additional cost to you.

Medical disclaimer: This article is for informational purposes only. It is not medical advice, diagnosis, or treatment. Not medical advice. Consult a qualified healthcare professional before changing your diet, exercise, or supplement regimen.

Each September, Japan’s Ministry of Health, Labour and Welfare publishes its centenarian survey — the count that reached more than 95,000 people aged 100 and older in 2025. That figure absorbs most of the attention. Within it sits a much smaller and less-discussed subset: the supercentenarian population — people who have reached age 110 — whose global total at any given time numbers in the low hundreds, and who appear in international validation databases at a rate that makes Japan’s demographic position even more pronounced than the centenarian figures alone suggest.

Understanding what that supercentenarian data actually shows requires working through two questions in sequence: how extreme ages are verified, and what research on people who reach 110 and beyond has established at the biological level. The first question determines which country rankings are meaningful. The second determines what conclusions the data can support.

The validation question: why Japan’s numbers are unusually reliable

Tracking centenarians at the national level depends on the quality of vital registration systems — birth records, death records, and the administrative thread linking them across a lifetime. Japan’s koseki (家族登録制度), the family registry system maintained continuously since the Meiji era, provides unusually complete documentation for extreme age claims. Every Japanese citizen’s birth, marriage, and death is registered in a lineage record maintained across local government offices. Universal health insurance enrollment, established in 1961, adds a parallel administrative record of medical contact starting from early life for generations who are now reaching extreme old age.

LongeviQuest — the principal organization maintaining the validated global database of supercentenarians, formerly operating as the Gerontology Research Group — uses a multi-step verification process requiring original birth records, identity documentation, and corroborating sources. When LongeviQuest validates a Japanese supercentenarian, the supporting documentation typically draws on koseki records maintained with consistent administrative custody across a century or more.

That documentation quality is not universal across countries. A 2019 demographic analysis published in PLOS ONE (Newman, S.) examined geographic distributions of validated supercentenarians and identified a pattern: regions with less complete vital registration systems showed unusual statistical anomalies in their extreme-longevity data, raising the question of whether some high-supercentenarian counts reflect data incompleteness rather than genuine survival. The analysis generated methodological debate and its conclusions remain contested in the field, but it drew attention to a less-discussed variable in international comparisons: the reliability of age documentation varies substantially by country and birth decade.

The practical consequence for interpreting rankings: Japan’s strong representation in validated global supercentenarian databases reflects both the biological survival rates of a specific population and the administrative quality of its records. The two are not separable in the aggregate statistics. When comparing Japan’s figures to those of countries with weaker historical vital registration, the comparison is partly a comparison of documentation systems, not only of biological longevity.

Japan in the current global supercentenarian data

MHLW’s September 2025 centenarian survey put Japan’s total 100-and-older population at more than 95,000, with women comprising approximately 88% of the count — a proportion stable across the survey’s 44-year history. Within that total, the supercentenarian population (110-plus) is tracked through both MHLW administrative records and international validation databases.

Japan has consistently held a disproportionate share of the world’s validated supercentenarians. Multiple analyses of LongeviQuest’s database across the past decade have found Japan accounting for a larger share of validated 110-plus individuals than any other country, in both absolute counts and per-capita rates. The female skew intensifies at this threshold: among validated supercentenarians globally, the proportion who are women approaches or exceeds 90%, compared to 88% for Japan’s broader centenarian population.

The best-documented recent case is Kane Tanaka. Born January 2, 1903, in Fukuoka Prefecture, she died April 19, 2022, at age 119 years and 107 days — a verified age certified by Guinness World Records, who recognized her as the world’s oldest living person from 2019 until her death. She is one of a small number of people in documented human history whose lifespan has been verified beyond 119 years. The oldest verified lifespan on record remains Jeanne Calment of France, who died in 1997 at 122 years and 164 days.

As of mid-2026, LongeviQuest’s validated living supercentenarian list continues to be disproportionately Japanese, consistent with the decade-long pattern. Specific individual rankings shift frequently at this population threshold as status changes; citing named individuals at publication carries a high probability of becoming outdated within months. Readers following the current list directly should consult LongeviQuest’s live database, which updates as validations are confirmed or individuals’ status changes.

What the longevity research on 110-plus outliers shows

The biology of supercentenarians — why some people reach 110 when most do not reach 90 — has been examined using the same cohort methods applied to centenarian research, but with sample sizes that limit what can be concluded firmly.

Genetic factors appear to carry more explanatory weight at extreme ages. The FOXO3 gene variant documented at elevated frequency in Japanese centenarians — in research published in PNAS (Willcox BJ et al., 2008) using Okinawa Centenarian Study data, subsequently replicated across Japanese and non-Japanese cohorts — remains the most consistently replicated genetic association in longevity research across populations. In supercentenarian cohorts specifically, research has found elevated frequencies of variants associated with cellular repair mechanisms, immune regulation, and telomere maintenance. Sample sizes in supercentenarian-specific studies are small enough that individual studies cannot establish firm causal models; the directional pattern across programs is consistent with genetic predisposition contributing substantially more at this threshold than behavioral factors alone can account for.

The mortality plateau hypothesis remains active but unresolved. Standard actuarial models predict that mortality hazard increases continuously with age. A body of demographic research — including a 2018 analysis published in Science (Barbi E et al.) using Italian supercentenarian data — has documented that above approximately age 105-110, the rate of increase in mortality appears to slow, approaching a plateau rather than continuing to accelerate. If confirmed at scale, this would suggest that people who survive past 110 face a different mortality risk architecture than the actuarial curves for younger-old populations predict. Newman’s 2019 PLOS ONE analysis raised methodological objections relevant to some of the underlying data. The plateau hypothesis is neither established nor dismissed in the current literature; it is one of the more actively debated questions in extreme-aging demography.

Dietary and lifestyle patterns become harder to isolate at extreme ages. The food patterns associated with Japanese longevity regions — regular oily fish, fermented soy, high vegetable variety, modest caloric intake — appear consistently in cohort data covering the 95–105 age range. At 110 and above, the population is too small for dietary cohort analysis, and survivor selection effects become the dominant interpretive challenge. Jeanne Calment reportedly consumed chocolate regularly and drank port wine — a dietary profile that does not match the dietary literature on Japanese longevity regions. The most supportable generalization from the extreme-age data is that reaching 110 likely requires a combination of genetic predisposition and the absence of accumulated fatal environmental insults — not adherence to any specific regimen. The dietary correlate that appears most consistently at extreme ages is the absence of severe nutritional deprivation, not a specific pattern.

Where the science reaches its structural limits

Supercentenarian research faces a constraint that is more acute here than anywhere else in the aging literature: there are too few people to study. At any moment, the world has perhaps 300–500 individuals whose age above 110 can be reliably verified. That population limits statistical power substantially and means that findings from supercentenarian cohorts are primarily hypothesis-generating rather than clinically conclusive.

Survivor selection is the second constraint, and it is inescapable. People who reach 110 have, by definition, survived everything that eliminated those who did not. Observations about their genetic variants, dietary habits, or behavioral patterns reflect the configuration of factors compatible with extreme survival — a configuration that may not generalize to populations with different genetic backgrounds, different historical exposures, or different medical contexts.

MHLW’s supercentenarian data captures the outcomes of people who grew up in specific periods of Japanese history — including wartime food restriction, postwar economic recovery, and the development of Japan’s universal healthcare infrastructure. The factors that contributed to their survival include conditions specific to those historical moments alongside more general biological patterns. This is the same interpretive constraint that applies to all centenarian cohort research but becomes sharper as the population shrinks.

Following this research

For primary data, MHLW publishes its centenarian and supercentenarian survey each September. LongeviQuest publishes its validated living list with continuous updates. The Okinawa Centenarian Study, now in its fourth decade, produces periodic publications through the Willcox research group.

The broader centenarian research base underlying the supercentenarian data — the documented dietary and behavioral patterns from Japan’s 100-plus cohorts in Okinawa, Kyotango, and Nagano — is examined in Japan’s 2025 Centenarian Record: 95,000+ and Why the Number Keeps Rising and in the 2025–2026 regional research roundup at Japan’s Blue Zones in 2026: What the Updated Research Shows. The 2026 Aging Society White Paper’s coverage of the centenarian count and healthy life expectancy gap is at Japan Aging Society White Paper 2026.

For English-language books covering the science of extreme longevity — including primary research summaries from the Okinawa Centenarian Study, the PNAS FOXO3 work, and the demographics of supercentenarian populations — supercentenarian and extreme longevity science books on Amazon covers the principal academic and popular science treatments. For the genetics of aging specifically, genetics of aging and longevity research books on Amazon covers primary research syntheses from the centenarian and extreme-aging literature.